Healthy snacks can help you maintain muscle mass and keep side effects in check while you’re working toward your weight loss ...

More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...

The Atlanta-based medical weight loss company has big plans for Tampa Bay, including a large new facility and substantial ...

Drugs that bind to and activate the receptors for the hormones GLP-1 and GIP are effective in the treatment of obesity and ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

Pfizer said it still expects adjusted 2025 profit of $2.80 a share to $3 a share, while analysts expect full-year earnings of $2.94 a share. The company continued to forecast 2025 revenue of $61 ...

Wegovy and Zepbound, the two leading weight-loss drugs, together sold less than $5 billion in 2023, according to ...

Glargine U300 use was common, especially with increased CKD stages and baseline HbA1c levels among patients with type 2 diabetes.

Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from ...

The likelihood for antibody-mediated rejection in lung transplant recipients was heightened with vs. without GLP-1 receptor ...

The Trump administration this month scrapped a Biden-era proposal that would have required state Medicaid programs and ...

The companies, which have at times had an adversarial relationship, also said they would develop a roadmap to continue their ...